2024 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
6.6 M |
-16.8 % |
2023 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
7.9 M |
-15.1 % |
2022 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
9.3 M |
-26.7 % |
2021 |
Denali Therapeutics Inc
|
- |
12.7 M |
36.2 % |
2021 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
12.7 M |
36.2 % |
2020 |
Denali Therapeutics Inc
|
- |
9.3 M |
86.8 % |
2020 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
9.3 M |
86.8 % |
2020 |
Denali Therapeutics Inc
|
- |
9.3 M |
86.8 % |
2019 |
Denali Therapeutics Inc
|
- |
5.0 M |
-16.8 % |
2019 |
Denali Therapeutics Inc
|
- |
5.0 M |
-16.8 % |
2019 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
5.0 M |
-16.8 % |
2018 |
Denali Therapeutics Inc
|
- |
6.0 M |
337.8 % |
2018 |
Denali Therapeutics Inc
|
- |
6.0 M |
337.8 % |
2018 |
Denali Therapeutics Inc
|
Director, President and Chief Executive Officer |
6.0 M |
337.8 % |
2017 |
Denali Therapeutics Inc
|
- |
1.4 M |
125.0 % |
2017 |
Denali Therapeutics Inc
|
- |
1.4 M |
125.0 % |
2017 |
Denali Therapeutics Inc
|
President, Chief Executive Officer and Director |
1.4 M |
125.0 % |
2016 |
Denali Therapeutics Inc
|
- |
607.5 K |
- |
2016 |
Denali Therapeutics Inc
|
- |
607.5 K |
- |
2016 |
Denali Therapeutics Inc
|
President, Chief Executive Officer and Director |
607.5 K |
- |